Miv Therapeutics, Inc. (IVT) Tops Q4 EPS by 7c

Miv Therapeutics, Inc. (NYSE: IVT) reported Q4 EPS of $0.04, $0.07 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $64.33 million versus the consensus estimate of $64.12 million.

For earnings history and earnings-related data on Miv Therapeutics, Inc. (IVT) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Duos Technologies Group, Inc. (DUOT) Tops Q2 EPS by 163c
• Tango Therapeutics Inc. (TNGX) PT Raised to $68 at H.C. Wainwright